BY CHRISTIAN BUNDGAARD
-
Big investor names main problem for Novo Nordisk equity
Novo Nordisk is fighting against legal copy drugs in the US, making up significant share of the GLP-1 market. This affects sales and thus share price, says investor.
-
Zealand Pharma re-elects all existing board members at annual general meeting
The seven board members elected at the AGM will thus continue with the biotech company for another year.
-
Why 1440 prefers CPMs for its newsletter business over other pricing models
Although 1440 has actually made use of the certified public accountant and CPC prices designs in previous years, the e-newsletter business is presently concentrated on CPM prices a…
-
Sanofi’s chlamydia vaccine candidate granted special status by US FDA
The candidate has not but been examined in medical research.
-
Eli Lilly teases Novo Nordisk after share price slide
Eli Lilly’s head of diabetes and weight problems enterprise factors to Novo Nordisk’s disappointment with its subsequent weight-loss blockbuster as a part of the explanation.
-
Novo Nordisk toppled as Europe’s largest listed company
Novo Nordisk loses the highest spot in Europe after its share value has roughly halved since reaching a file excessive in June.
-
Novo Nordisk expands Wegovy savings program in the US
Currently, without insurance people can get Wegovy at their regional “trusted” United States drug store for USD 499 a month.
-
Novo Nordisk signs billion-dollar deal with Chinese biotech company
The arrangement worries an anti-obesity and anti-diabetes medication. The prospect is a three-way agonist that turns on 3 various receptors all at once.
-
Augustine Therapeutics raises EUR 77.7m – Novo Holdings among the investors
The Belgian biotech firm’s lead prospect will certainly be evaluated in Charcot-Marie-Tooth condition (CMT), various other neurodegenerative conditions and cardiometabolic co…
-
Radiometer presents new savings plan: Hiring freeze and reduced salary increases
Just staff members with the ideal efficiency rating will certainly obtain their raise this year, albeit cut in half.
